← All patents

US11065285B2

Biomarkers and combination therapies using oncolytic virus and immunomodulation

University of Texas System

Abstract

The invention disclosed herein describes biomarkers useful for prognosis, selection and monitoring of oncolytic virus therapy for patients with various types of cancer. In particular, the present invention provides identification of proteins whose expression patterns are strongly predictive of the …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Frank Tufaro
Priority date
January 25, 2012
Filing date
June 30, 2020
Grant date
July 20, 2021
Publication date
July 20, 2021
Language
en
Metadata fetched
August 29, 2026 00:27